Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Biohaven (BHVN) Acquisitions (2024)

Biohaven has reported Acquisitions over the past 1 years, most recently at $391000.0 for Q1 2024.

Quarterly results put Acquisitions at $391000.0 for Q1 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $391000.0 (changed N/A YoY), and the annual figure for FY2024 was $391000.0, changed.
Acquisitions reached $391000.0 in Q1 2024 per BHVN's latest filing.
Across five years, Acquisitions topped out at $391000.0 in Q1 2024 and bottomed at $391000.0 in Q1 2024.